Day 4. May 12, 2016 After the Chair Summary of the previous discussions on libraries and archives limitations and exceptions we heard the goup statements. In brief, Group B (the rich countries) stated that the discussions should continue to get… Continue Reading
>> EIFL.NET: I will start with retracted and withdrawn works. So libraries and archives have a mandate to pre seven public record for the future. In the analog aenvironment exhaustion to the distribution right provides legal means to insure its… Continue Reading
>> SAA: Thank you, Mr. Chair. Orphan works, what an appropriate name for the stuff of everyday life that we all create? Diaries, business memos and photographs that we never bother to mark with our own names. Most of it… Continue Reading
Speaking on behalf of the American University programme on information justice and Intellectual Property. And I speak as an educator myself and also on behalf of a larger network that I coordinate called the global expert network on user rights which is a network of educators.April 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents
SCCR 32 KEI on Orphan Works
KEI Statement SCCR 32 Day 4 on “Orphan works” and Libraries and Archives
I will be speaking here as a user of libraries and archives and as a user of out of print and orphan works for my past academic work and my research today.
April 27, 2016 Letter from Colombian Embassy regarding Senate Finance, USTR pressure on Novartis compulsory license
Senator Hatch, before pressuring Colombia over cancer drug compulsory license, wanted one for Napster
(More on Colombia here: /colombia)
Continue ReadingFundación Karisma at WIPO SCCR32 on broadcast treaty
Good afternoon, and thank you very much, sir.
I wanted to refer to the rights to be granted in this proposed treaty and I would like to give you an example of something that has recently happened in Colombia and how sometimes the retransmission rights can be abused.2016: Dedalus Pharma, LLC, KEI comments on NIH proposal for exclusive licenses on CARs to treat cancer
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On April 22nd, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Dedalus… Continue Reading
